GBR-900

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameGBR-900
Drug Alias NamehMNAC-13BXL-1H5GBR-900MNAC-13
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionNerve growth factor receptor Trk-A antagonists
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLay Line Genomics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlenmark Pharmaceuticals SaBioxell IncGlenmark Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A